Live News Categoriesmarket

326030 (326030) News

Follow 326030 (326030) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 326030 Asset market Sector Markets 90 days 1 Updated Sep 10, 2026, 11:34 AM UTC Open live news feed

M US FDA imposes partial clinical hold on Biohaven epilepsy trials Biohaven said the U.S. FDA imposed a partial clinical hold, pausing new patient enrollment in its experimental epilepsy drug trials after rodent findings. The company’s shares fell more than 13% in premarket trading. REGULATION | Sep 10, 2026, 11:34 AM UTC